Item
L-Choline Bitartrate (P1289-01)
Jinan Asia Pharmaceutical Co., Ltd.
Choline L (+) Bitartrate & water
Nutrient / Vitamin
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| H&M USA INC. | 80 Gordon Drive Syosset, NY 11791 |
| H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | North side of 249 Provincial Road Xishi Town Jinan, SD 250413 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | H&M USA INC. | Allergens.pdf | 3/25/2025 | 3/25/2027 |
| Allergens | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | Allergens.pdf | 3/25/2025 | 3/25/2027 |
| Country of Origin | H&M USA INC. | Country of Origin.pdf | 4/3/2025 | 4/2/2028 |
| Country of Origin | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | Country of Origin.pdf | 4/3/2025 | 4/2/2028 |
| Dietary Supplement Questionnaire | H&M USA INC. | Dietary Supplement Questionnaire.pdf | 4/3/2025 | 4/3/2026 |
| Dietary Supplement Questionnaire | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | Dietary Supplement Questionnaire.pdf | 4/3/2025 | 4/3/2026 |
| Kosher | H&M USA INC. | Kosher Cert_Jinan Asia_033126.pdf | 4/4/2025 | 3/31/2026 |
| National Bioengineered Food Disclosure Standard (Simplified) | H&M USA INC. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 4/3/2025 | 4/2/2028 |
| National Bioengineered Food Disclosure Standard (Simplified) | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 4/3/2025 | 4/2/2028 |
| Organic | H&M USA INC. | NotApplicable_Organic.pdf | 3/20/2025 | 3/20/2027 |
| Nutrition | H&M USA INC. | Nutrition.pdf | 4/3/2025 | 4/2/2028 |
| Nutrition | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | Nutrition.pdf | 4/3/2025 | 4/2/2028 |
| Animal Testing Statement | H&M USA INC. | P1289-01 - Animal Testing.pdf | 4/3/2025 | 4/3/2027 |
| Animal Testing Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Animal Testing.pdf | 4/3/2025 | 4/3/2027 |
| BSE - TSE | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - BSE-TSE.pdf | 4/3/2025 | 4/2/2028 |
| BSE - TSE | H&M USA INC. | P1289-01 - BSE-TSE.pdf | 4/3/2025 | 4/2/2028 |
| Ingredient Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Composition.pdf | 4/3/2025 | 4/2/2028 |
| Ingredient Statement | H&M USA INC. | P1289-01 - Composition.pdf | 4/3/2025 | 4/2/2028 |
| HACCP Process Flow Diagram | H&M USA INC. | P1289-01 - Flow Chart.pdf | 4/3/2025 | 4/3/2027 |
| HACCP Process Flow Diagram | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Flow Chart.pdf | 4/3/2025 | 4/3/2027 |
| Gluten | H&M USA INC. | P1289-01 - Gluten.pdf | 4/3/2025 | 4/3/2027 |
| Gluten | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Gluten.pdf | 4/3/2025 | 4/3/2027 |
| GMO | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - GMO.pdf | 4/3/2025 | 4/3/2027 |
| GMO | H&M USA INC. | P1289-01 - GMO.pdf | 4/3/2025 | 4/3/2027 |
| GRAS/NDI/ODI Statement | H&M USA INC. | P1289-01 - GRAS.pdf | 4/3/2025 | 4/2/2028 |
| GRAS/NDI/ODI Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - GRAS.pdf | 4/3/2025 | 4/2/2028 |
| Halal | H&M USA INC. | P1289-01 - Halal.pdf | 1/15/2025 | 12/31/2026 |
| Halal | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Halal.pdf | 1/15/2025 | 12/31/2026 |
| Heavy Metal | H&M USA INC. | P1289-01 - Heavy Metals.pdf | 3/25/2025 | 3/25/2027 |
| Heavy Metal | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Heavy Metals.pdf | 3/25/2025 | 3/25/2027 |
| Irradiation Status Statement | H&M USA INC. | P1289-01 - Irradiation.pdf | 4/3/2025 | 4/3/2027 |
| Irradiation Status Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Irradiation.pdf | 4/3/2025 | 4/3/2027 |
| Pesticide | H&M USA INC. | P1289-01 - Pesticides.pdf | 4/3/2025 | 4/3/2027 |
| Pesticide | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Pesticides.pdf | 4/3/2025 | 4/3/2027 |
| California Prop. 65 | H&M USA INC. | P1289-01 - Prop 65.pdf | 4/3/2025 | 4/3/2027 |
| California Prop. 65 | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Prop 65.pdf | 4/3/2025 | 4/3/2027 |
| Residual Statement | H&M USA INC. | P1289-01 - Residual Solvents.pdf | 4/3/2025 | 4/3/2026 |
| Residual Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Residual Solvents.pdf | 4/3/2025 | 4/3/2026 |
| CoA Sample | H&M USA INC. | P1289-01 - Sample CoA.pdf | 3/25/2025 | 3/25/2027 |
| CoA Sample | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Sample CoA.pdf | 3/25/2025 | 3/25/2027 |
| Safety Data Sheet (SDS) | H&M USA INC. | P1289-01 - SDS.pdf | 4/3/2025 | 4/2/2028 |
| Safety Data Sheet (SDS) | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - SDS.pdf | 4/3/2025 | 4/2/2028 |
| Sewage Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Sewage Sludge.pdf | 4/3/2025 | 4/3/2027 |
| Sewage Statement | H&M USA INC. | P1289-01 - Sewage Sludge.pdf | 4/3/2025 | 4/3/2027 |
| Product Specification Sheet | H&M USA INC. | P1289-01 - Spec.pdf | 4/3/2025 | 4/2/2028 |
| Product Specification Sheet | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Spec.pdf | 4/3/2025 | 4/2/2028 |
| No Animal Ingredient Statement | H&M USA INC. | P1289-01 - Vegan.pdf | 3/25/2025 | 3/25/2026 |
| Vegan/Vegetarian Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - Vegan.pdf | 4/3/2025 | 4/3/2027 |
| Vegan/Vegetarian Statement | H&M USA INC. | P1289-01 - Vegan.pdf | 4/3/2025 | 4/3/2027 |
| WADA/NSF/NFL Statement | H&M USA INC. | P1289-01 - WADA.pdf | 4/3/2025 | 4/3/2027 |
| WADA/NSF/NFL Statement | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | P1289-01 - WADA.pdf | 4/3/2025 | 4/3/2027 |
| Suitability Requirements | H&M USA INC. | Suitability Requirements.pdf | 4/3/2025 | 4/2/2028 |
| Suitability Requirements | H&M USA INC. - Jinan Asia Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 4/3/2025 | 4/2/2028 |
